COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF BLEOMYCIN AND ETHOXYSCLEROL IN THE TREATMENT OF VENOUS MALFORMATIONS: Experience of the A.N. Syzganov National Scientific Center of Surgery
BULLETIN OF SURGERY OF KAZAKHSTAN · 2025
DOI: 10.35805/bsk2025iv006 ↗Kurz gefasst
Fachartikel in der Zeitschrift BULLETIN OF SURGERY OF KAZAKHSTAN, 2025. Verfasst von Alisher Kozhamkul und 6 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Venous malformations represent congenital slow-flow vascular anomalies accounting for 45–60% of all vascular malformations. They arise from developmental defects of venous channels and are frequently associated with chronic pain, swelling, cosmetic deformity, and functional limitations. Materials and Methods: A retrospective analysis included 40 patients with venous malformations treated at the A.N. Syzganov National Scientific Center of Surgery (2019–2024). Patients underwent two ultrasound-guided sclerotherapy sessions and were assigned to bleomycin (n = 20) or ethoxysclerol (n = 20). Outcomes included lesion-volume reduction on magnite resonance / ultrasound and changes in EQ-5D-5L and EQ-VAS scores.
Results
Mean venous malformations volume reduction after two sessions was 32.2 ± 10.1% with bleomycin and 29.6 ± 12.3% with ethoxysclerol (p = 0.42). EQ-5D-5L improved by +0.20 and +0.16, respectively (p = 0.40). Although baseline EQ-VAS was higher in the ethoxysclerol group, the gain was greater with bleomycin (+13.2 vs. +7.5; p = 0.06). No severe complications were registered; mild reactions occurred in 27.5%. Predictors of ≥50% regression were baseline lesion volume < 35 cm³ (OR = 2.8; p = 0.02) and body mass index < 27 kg/m² (OR = 2.3; p = 0.04).
Conclusion
Both sclerosants are effective and safe for treating venous malformations. Bleomycin showed a trend toward greater subjective improvement and fewer additional procedures. Personalized agent selection should consider lesion volume, body mass index, and individual clinical features.
Zitieren
APA
Kozhamkul, A., Abilkhanov, Y., Zhakubayev, M., Sapunov, A., Berkinbay, A., Saduakas, A., & Demeuov, T. (2025). COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF BLEOMYCIN AND ETHOXYSCLEROL IN THE TREATMENT OF VENOUS MALFORMATIONS: Experience of the A.N. Syzganov National Scientific Center of Surgery. BULLETIN OF SURGERY OF KAZAKHSTAN. https://doi.org/10.35805/bsk2025iv006
Vancouver
Kozhamkul A, Abilkhanov Y, Zhakubayev M, Sapunov A, Berkinbay A, Saduakas A, et al. COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF BLEOMYCIN AND ETHOXYSCLEROL IN THE TREATMENT OF VENOUS MALFORMATIONS: Experience of the A.N. Syzganov National Scientific Center of Surgery. BULLETIN OF SURGERY OF KAZAKHSTAN. 2025. doi:10.35805/bsk2025iv006
BibTeX
@article{Kozhamkul2025,
author = {Kozhamkul, Alisher and Abilkhanov, Yerzhan and Zhakubayev, M and Sapunov, Alexander and Berkinbay, A and Saduakas, A and Demeuov, T},
title = {COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF BLEOMYCIN AND ETHOXYSCLEROL IN THE TREATMENT OF VENOUS MALFORMATIONS: Experience of the A.N. Syzganov National Scientific Center of Surgery},
journal = {BULLETIN OF SURGERY OF KAZAKHSTAN},
year = {2025},
doi = {10.35805/bsk2025iv006}
}
EUVIMED